BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tovo PA, Garazzino S, Daprà V, Pruccoli G, Calvi C, Mignone F, Alliaudi C, Denina M, Scolfaro C, Zoppo M, Licciardi F, Ramenghi U, Galliano I, Bergallo M. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases. Int J Mol Sci 2021;22:7481. [PMID: 34299101 DOI: 10.3390/ijms22147481] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Johnson E, Salari K, Yang S. SETDB1: A perspective into immune cell function and cancer immunotherapy. Immunology 2022. [DOI: 10.1111/imm.13619] [Reference Citation Analysis]
2 Rangel SC, da Silva MD, da Silva AL, Dos Santos JMB, Neves LM, Pedrosa A, Rodrigues FM, Trettel CDS, Furtado GE, de Barros MP, Bachi ALL, Romano CM, Nali LHDS. Human endogenous retroviruses and the inflammatory response: A vicious circle associated with health and illness. Front Immunol 2022;13:1057791. [PMID: 36518758 DOI: 10.3389/fimmu.2022.1057791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sharif-askari NS, Sharif-askari FS, Hafezi S, Kalaji Z, Temsah M, Almuhsen S, Alsafar HS, Hamid Q, Halwani R. Airways tissue expression of type I interferons and their stimulated genes is higher in children than adults. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11724] [Reference Citation Analysis]
4 Jin X, Li X, Guan F, Zhang J. Human Endogenous Retroviruses and Toll-Like Receptors. Viral Immunology 2022. [DOI: 10.1089/vim.2022.0090] [Reference Citation Analysis]
5 Tavakoli R, Rahimi P, Hamidi-Fard M, Eaybpoush S, Doroud D, Ahmadi I, Anvari E, Aghasadeghi M, Fateh A. Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection. Virol J 2022;19:156. [PMID: 36192760 DOI: 10.1186/s12985-022-01885-0] [Reference Citation Analysis]
6 Sorek M, Meshorer E, Schlesinger S. Impaired activation of transposable elements in SARS-CoV-2 infection. EMBO Rep 2022;23:e55101. [PMID: 35972201 DOI: 10.15252/embr.202255101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Simula ER, Manca MA, Noli M, Jasemi S, Ruberto S, Uzzau S, Rubino S, Manca P, Sechi LA, Mostafa HH. Increased Presence of Antibodies against Type I Interferons and Human Endogenous Retrovirus W in Intensive Care Unit COVID-19 Patients. Microbiol Spectr. [DOI: 10.1128/spectrum.01280-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cho JY, Kim J, Kim J, Lee D, Kim D, Kim Y, Lee JH, Nam B, Kim Y, Kong HJ. Characterization of TRIM16, a member of the fish-specific finTRIM family, in olive flounder Paralichthys olivaceus. Fish & Shellfish Immunology 2022. [DOI: 10.1016/j.fsi.2022.07.003] [Reference Citation Analysis]
9 Mouliou DS, Dardiotis E. Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing? Mult Scler Relat Disord 2022;64:103938. [PMID: 35717898 DOI: 10.1016/j.msard.2022.103938] [Reference Citation Analysis]
10 Milani D, Caruso L, Zauli E, Al Owaifeer AM, Secchiero P, Zauli G, Gemmati D, Tisato V. p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics). Front Pharmacol 2022;13:871583. [DOI: 10.3389/fphar.2022.871583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tovo PA, Davico C, Marcotulli D, Vitiello B, Daprà V, Calvi C, Montanari P, Carpino A, Galliano I, Bergallo M. Enhanced Expression of Human Endogenous Retroviruses, TRIM28 and SETDB1 in Autism Spectrum Disorder. Int J Mol Sci 2022;23:5964. [PMID: 35682642 DOI: 10.3390/ijms23115964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Pellegrina D, Bahcheli AT, Krassowski M, Reimand J. Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants. Mol Syst Biol 2022;18:e10823. [PMID: 35579274 DOI: 10.15252/msb.202110823] [Reference Citation Analysis]
13 Sagulkoo P, Suratanee A, Plaimas K. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 2022;12:690. [DOI: 10.3390/biom12050690] [Reference Citation Analysis]
14 Israeli M, Finkel Y, Yahalom-Ronen Y, Paran N, Chitlaru T, Israeli O, Cohen-Gihon I, Aftalion M, Falach R, Rotem S, Elia U, Nemet I, Kliker L, Mandelboim M, Beth-Din A, Israely T, Cohen O, Stern-Ginossar N, Bercovich-Kinori A. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2. Nat Commun 2022;13:2237. [PMID: 35469023 DOI: 10.1038/s41467-022-29896-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Fukuda Y, Homma T, Inoue H, Goto Y, Sato Y, Ikeda H, Onitsuka C, Sato H, Akimoto K, Ebato T, Suganuma H, Kawahara T, Mikuni H, Uchida Y, Suzuki S, Tanaka A, Sagara H. Serum IL-28A/IFN-λ2 is linked to disease severity of COVID-19. Sci Rep 2022;12:5458. [PMID: 35361913 DOI: 10.1038/s41598-022-09544-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Randolph K, Hyder U, D’orso I. KAP1/TRIM28: Transcriptional Activator and/or Repressor of Viral and Cellular Programs? Front Cell Infect Microbiol 2022;12:834636. [DOI: 10.3389/fcimb.2022.834636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
17 Durnaoglu S, Lee S, Ahnn J. Syncytin, envelope protein of human endogenous retrovirus (HERV): no longer ‘fossil’ in human genome. Animal Cells and Systems 2021;25:358-68. [DOI: 10.1080/19768354.2021.2019109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Pellegrina D, Bahcheli AT, Krassowski M, Reimand J. Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants.. [DOI: 10.1101/2021.11.22.21266712] [Reference Citation Analysis]
19 Higgins CA, Nilsson-payant BE, Kurland AP, Ye C, Yaron T, Johnson JL, Bonaventure B, Adhikary P, Golynker I, Panis M, Danziger O, Rosenberg BR, Cantley LC, Martinez-sobrido L, tenOever BR, Johnson JR. SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.. [DOI: 10.1101/2021.08.20.457146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Israeli M, Finkel Y, Yahalom-ronen Y, Paran N, Chitlaru T, Israeli O, Cohen-gihon I, Aftalion M, Falach R, Elia U, Nemet I, Kliker L, Mandelboim M, Beth-din A, Israely T, Cohen O, Stern-ginossar N, Bercovich-kinori A. CRISPR screens for host factors critical for infection by SARS-CoV-2 variants of concern identify GATA6 as a central modulator of ACE2.. [DOI: 10.1101/2021.07.19.452809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]